Skip to main content
. 2021 Nov 23;107(4):e1549–e1557. doi: 10.1210/clinem/dgab832

Figure 1.

Figure 1.

Cumulative incidence curves comparing incidence of T2DM in TGD participants and their matched referents. Top row shows results for the overall TF cohort followed from the index date (left panel) and for the TF cohort followed from HT initiation date (right panel). Bottom row shows results for the overall TM cohort followed from the index date (left panel) and for the TM cohort followed from HT initiation date (right panel). Abbreviations: CF, cisgender female; CM, cisgender male; HT, hormone therapy; T2DM, type 2 diabetes mellitus; TF, transfeminine; TGD, transgender and gender nonconforming; TM, transmasculine.